Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 741-754     DOI: 10.31083/j.rcm2203081
Special Issue: New insight in Cardiovascular Imaging
Review Previous articles | Next articles
Role of transthoracic echocardiogram in acute heart failure
Sarah Fitzsimons1, 2, *(), Robert N Doughty1, 2
1Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 1023 Auckland, New Zealand
2Greenlane Cardiovascular Service, Auckland District Health Board, 1023 Auckland, New Zealand
Download:  PDF(554KB)  ( 237 ) Full text   ( 17 )
Export:  BibTeX | EndNote (RIS)      
Acute Heart Failure (AHF) is an increasingly common condition with a poor prognosis. In contrast to CHF where advances in medical therapy and devices has led to significant improvement in morbidity and mortality, the prognosis for AHF has not changed significantly in the last few decades despite efforts to find effective treatment. There are multiple factors that contribute to the high mortality and morbidity of AHF; it can be a diagnostic challenge, determining whether decongestion has been achieved can be difficult, and persisting congestion is commonly present at discharge contributing to early decompensation and rehospitalisation. Transthoracic echocardiogram (TTE) is a unique imaging modality that is non-invasive, can be done at the bedside, in real time during procedures, is affordable and easy to access both in community and inpatient settings. Small hand held 'point of care' scans are increasingly available and being used as an adjunct to improve clinical examination. Consequently, the use of echocardiography to improve outcomes for patients with cardiac disease continues to evolve. In chronic heart failure TTE has established roles in the quantification of HF phenotype, and determination of treatment initiation, escalation and success. However, the role of echocardiogram in AHF is not as well established with society guidelines relying on expert consensus for their recommendations. Use of TTE at all stages of AHF has potential to reduce morbidity and mortality. This review discusses the evidence for use of TTE to improve the diagnosis, prognosis and management of AHF.
Key words:  Acute heart failure      Transthoracic echocardiogram      Diagnosis      Prognosis      Treatment     
Submitted:  01 July 2021      Revised:  01 August 2021      Accepted:  06 August 2021      Published:  24 September 2021     
*Corresponding Author(s):  Sarah Fitzsimons     E-mail:

Cite this article: 

Sarah Fitzsimons, Robert N Doughty. Role of transthoracic echocardiogram in acute heart failure. Reviews in Cardiovascular Medicine, 2021, 22(3): 741-754.

URL:     OR

[1] Peter A. McCullough, Raphael B. Stricker, Harvey A. Risch. Role of hydroxychloroquine in multidrug treatment of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 545-546.
[2] Hongbo Gan, Heng Tang, Yujie Huang, Dan Wang, Peng Pu, Zhong Zuo. The 'diamond' approach to personalized drug treatment of heart failure with reduced ejection fraction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 573-584.
[3] Yaowang Lin, Yang Chen, Jie Yuan, Xinli Pang, Huadong Liu, Shaohong Dong, Qiuling Chen. Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 865-872.
[4] Florina Caruntu, Diana Aurora Bordejevic, Mirela Cleopatra Tomescu, Ioana Mihaela Citu. Clinical characteristics and outcomes in acute myocardial infarction patients aged ≥65 years in Western Romania[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 911-918.
[5] Matthieu MILLION, Jean-Christophe LAGIER, Hervé TISSOT-DUPONT, Isabelle RAVAUX, Catherine DHIVER, Christelle TOMEI, Nadim CASSIR, Léa DELORME, Sébastien CORTAREDONA, Sophie AMRANE, Camille AUBRY, Karim BENDAMARDJI, Cyril BERENGER, Barbara DOUDIER, Sophie EDOUARD, Marie HOCQUART, Morgane MAILHE, Coralie PORCHETO, Piseth SENG, Catherine TRIQUET, Stéphanie GENTILE, Elisabeth JOUVE, Audrey GIRAUD-GATINEAU, Herve CHAUDET, Laurence CAMOIN-JAU, Philippe COLSON, Philippe GAUTRET, Pierre-Edouard FOURNIER, Baptiste MAILLE, Jean-Claude DEHARO, Paul HABERT, Jean-Yves GAUBERT, Alexis JACQUIER, Stéphane HONORE, Katell GUILLON-LORVELLEC, Yolande OBADIA, Philippe PAROLA, Philippe BROUQUI, Didier RAOULT. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1063-1072.
[6] Florina Căruntu, Diana Aurora Bordejevic, Bogdan Buz, Alexandru Gheorghiu, Mirela Cleopatra Tomescu. Independent predictors of in-hospital and 1-year mortality rates in octogenarians with acute myocardial infarction[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 489-497.
[7] Kevin Bryan Lo, Hesam Mostafavi Toroghi, Grace Salacup, Jiahui Jiang, Ruchika Bhargav, Eduardo Quintero, Kira Balestrini, Anum Shahzad, Roy O. Mathew, Peter A McCullough, Janani Rangaswami. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 199-206.
[8] Qing Lu, Jiu-Long Wang, Zhi-Nan Chen, Wen-Bo Fu, Hui-Jian Liu, Shi-Fang Ding. The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 247-256.
[9] Peter A. McCullough, Paul E. Alexander, Robin Armstrong, Cristian Arvinte, Alan F. Bain, Richard P. Bartlett, Robert L. Berkowitz, Andrew C. Berry, Thomas J. Borody, Joseph H. Brewer, Adam M. Brufsky, Teryn Clarke, Roland Derwand, Alieta Eck, John Eck, Richard A. Eisner, George C. Fareed, Angelina Farella, Silvia N. S. Fonseca, Charles E. Geyer Jr., Russell S. Gonnering, Karladine E. Graves, Kenneth B. V. Gross, Sabine Hazan, Kristin S. Held, H. Thomas Hight, Stella Immanuel, Michael M. Jacobs, Joseph A. Ladapo, Lionel H. Lee, John Littell, Ivette Lozano, Harpal S. Mangat, Ben Marble, John E. McKinnon, Lee D. Merritt, Jane M. Orient, Ramin Oskoui, Donald C. Pompan, Brian C. Procter, Chad Prodromos, Juliana Cepelowicz Rajter, Jean-Jacques Rajter, C. Venkata S. Ram, Salete S. Rios , Harvey A. Risch, Michael J. A. Robb, Molly Rutherford, Martin Scholz, Marilyn M. Singleton, James A. Tumlin, Brian M. Tyson, Richard G. Urso, Kelly Victory, Elizabeth Lee Vliet, Craig M. Wax, Alexandre G. Wolkoff, Vicki Wooll, Vladimir Zelenko. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 517-530.
[10] Marios Sagris, Damianos G Kokkinidis, Ioannis G. Lempesis, Stefanos Giannopoulos, Loukianos Rallidis, Carlos Mena-Hurtado, Christos Bakoyiannis. Nutrition, dietary habits, and weight management to prevent and treat patients with peripheral artery disease[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 565-575.
[11] Eric Bruckert, Gaelle Desamericq, Artak Khachatryan, Patrick Ngo, Gaelle Gusto, Francesc Sorio-Vilela. Patient characteristics, treatment patterns, and adherence to lipid-lowering therapies following an acute coronary syndrome[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 643-650.
[12] Malik Bisserier, Natasha Pradhan, Lahouaria Hadri. Current and emerging therapeutic approaches to pulmonary hypertension[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 163-179.
[13] Shi-Min Yuan. Cardiac and vascular causes of persistent fever: A systematic review[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 255-262.
[14] Girish Singhania, Abutaleb A. Ejaz, Peter A. McCullough, Aaron Y. Kluger, Saravanan Balamuthusamy, Bhagwan Dass, Namrata Singhania, Adhish Agarwal. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 111-120.
[15] Yun Tian, Pingji Deng, Bing Li, Jieqiong Wang, Ju Li, Yulan Huang, Yan Zheng. Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance[J]. Reviews in Cardiovascular Medicine, 2019, 20(1): 27-33.
No Suggested Reading articles found!